Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Resistance
HIV Resistance Testing Contract Awarded
September 3rd, 2000
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a contract to Virco, Baltimore, Maryland, to conduct the testing for the agency's pivotal survey of transmission of drug-resistant strains of HIV in the U.S. The most important criterion for awarding this type of contract is technical quality, followed by reasonable pricing. The contract includes VircoGEN II tests, Virco's genotypic resistance test that identifies mutations in the genetic code of HIV that cause drug resistance, and Antivirogram phenotypic tests, which measure the ability of the virus to grown in the presence of each of the drugs in the laboratory. Historically, a...
Source: Medical Letter on the CDC & FDA (2000-09-03)
|
